Receptor News and Research

RSS
Berkeley lab researchers link possible new oncogene with resistance to cancer drugs

Berkeley lab researchers link possible new oncogene with resistance to cancer drugs

Palatin fourth quarter revenues decrease to $11,000

Palatin fourth quarter revenues decrease to $11,000

KRAS gene mutation recruits second player to trigger pancreatic cancer

KRAS gene mutation recruits second player to trigger pancreatic cancer

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Combining two drugs may offer new and potent punch against cancer and other diseases

Combining two drugs may offer new and potent punch against cancer and other diseases

Phase III data for Suvorexant, an investigational insomnia medicine, announced

Phase III data for Suvorexant, an investigational insomnia medicine, announced

Heptares uses StaR technology to solve structure of CRF-1 receptor

Heptares uses StaR technology to solve structure of CRF-1 receptor

Soy-rich diet can mitigate effects of bisphenol A

Soy-rich diet can mitigate effects of bisphenol A

UH lecture to explore hormones in health and disease

UH lecture to explore hormones in health and disease

Trevena to present TRV027 Phase 1 clinical data at 16th Annual Heart Failure Society of America Meeting

Trevena to present TRV027 Phase 1 clinical data at 16th Annual Heart Failure Society of America Meeting

Crizotinib effective in shrinking tumors in patients with ALK positive non-small cell lung cancer

Crizotinib effective in shrinking tumors in patients with ALK positive non-small cell lung cancer

Boston researchers develop neonatal mouse model of sepsis

Boston researchers develop neonatal mouse model of sepsis

Constipation drug may bring US patients relief

Constipation drug may bring US patients relief

Merck, Symphogen announce worldwide license agreement for Sym004 to treat cancers

Merck, Symphogen announce worldwide license agreement for Sym004 to treat cancers

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

Lack of evidence to recommend routine screening for chronic kidney disease

Lack of evidence to recommend routine screening for chronic kidney disease

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

CLC bio announces acquisition of Molegro

CLC bio announces acquisition of Molegro

Heavy alcohol use rewires brain circuitry and increases risk of PTSD

Heavy alcohol use rewires brain circuitry and increases risk of PTSD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.